EGFR and tuberous sclerosis: However, inhibitors to Epidermal growth factor receptor (EGFR) and MAP kinse-ERK kinase (MEK) (a downstream molecule in the EGFR pathway) did not change the elevated level of EREG in TSC skin tumor (21).